Teachers Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Teachers Advisors’s Portfolio ONCT Stock Details ONCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-27	Closed	-$58K	–	3190
2014 Q1	$58K	Hold	27	–	–	﹤0.01%	3070
2013 Q4	$63K	Buy	27 +16	+145%	+$36.6K	﹤0.01%	3057
2013 Q3	$30K	Sell	11 -11	-50%	-$54.7K	﹤0.01%	3055
2013 Q2	$204K	Buy	+22	New	+$170K	﹤0.01%	2749

Other funds holding ONCT

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Teachers Advisors's ONCT Position: Q2 2014 in Review

Teachers Advisors sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2014, closing a stake of 27 shares — an estimated $58K sold.

Teachers Advisors first reported a position in ONCT in Q2 2013 and held it in 4 quarters. The position peaked at $204K in Q2 2013. 50 funds tracked by Wall St. Rank hold ONCT as of Q2 2014.

Teachers Advisors reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
Teachers Advisors sold 27 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2014, an estimated $58K.
Teachers Advisors first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 4 quarters.
Teachers Advisors's Oncternal Therapeutics, Inc. Common Stock position peaked at $204K in Q2 2013.
50 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2014.

Based on Teachers Advisors's 13F filing for Q2 2014, filed 13 Aug 2014.